This analysis describes what OpenAI's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
How other platforms handle this
You may not assign your rights under the Agreement, by operation of law or otherwise, without our consent.
Teladoc Health may assign, transfer, or delegate any of its rights and obligations hereunder without your consent.
This warranty will not apply if the error or non-conformance was caused by misuse of the Platform Services, modifications to the Platform Services by Customer or any third party, or third-party hardware, software, or services...
"Customer may object to the use of such additional Sub-processor within 30 days of receiving notice of the change by following the instructions set forth in the Sub-Processor List...Excerpt from OpenAI's Data Processing Addendum
Get the weekly coverage letter
Companies change their terms without announcing it. We capture governance documents, compare each new version with the last, and publish what changed, with the source text behind it. One email a week on what we found and what we could not reach.
The clause states: “Customer may object to the use of such additional Sub-processor within 30 days of receiving notice of the change by following the instructions set forth in the Sub-Processor List...”
ConductAtlas has identified this type of provision across 290 platforms. See the full comparison.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by OpenAI.